2019
DOI: 10.1016/j.eimce.2018.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and in vitro antifungal susceptibility of cryptic species of the genus Aspergillus isolated in clinical samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
2
1
0
Order By: Relevance
“…In our study, A. quadrilineatus exhibited low MIC values for azoles and echinocandin agents. Similarly, in two other published reports by Salah et al and Vidal‐Acuna et al, 23,28 posaconazole and anidulafungin showed potent in vitro activity against A. quadrilineatus . Moreover, in agreement with the study conducted by Vidal‐Acuna et al, 28 we found that amphotericin B had high MIC value against A. quadrilineatus .…”
Section: Discussionsupporting
confidence: 62%
See 1 more Smart Citation
“…In our study, A. quadrilineatus exhibited low MIC values for azoles and echinocandin agents. Similarly, in two other published reports by Salah et al and Vidal‐Acuna et al, 23,28 posaconazole and anidulafungin showed potent in vitro activity against A. quadrilineatus . Moreover, in agreement with the study conducted by Vidal‐Acuna et al, 28 we found that amphotericin B had high MIC value against A. quadrilineatus .…”
Section: Discussionsupporting
confidence: 62%
“…According to EORTC/MSG criteria, proven IFI is related to positive fungus in histology/culture of sterile tissue samples.In our study, A. quadrilineatus exhibited low MIC values for azoles and echinocandin agents. Similarly, in two other published reports by Salah et al and Vidal-Acuna et al,23,28 posaconazole and anidulafungin showed potent in vitro activity against A. quadrilineatus. With the appearance of fungal infections due to cryptic species and their possible resistance to routine antifungal agents, screening studies are highly recommended to evaluate the frequency of cryptic species, and more antifungal susceptibility data are needed before being recommended as first-line therapy against infections due to cryptic species in high-risk patients.All authors have made substantial contributions to the conception and acquisition of data, drafting of the article, and approval of the final version.…”
supporting
confidence: 64%
“…Among these fungi, Aspergillus was first described in 1729. 1,2 For over three centuries approximately 250 species have been recognized in the genus. 3,4 Some species of Aspergillus have negatively affected man in so many areas of life, both medically and commercially.…”
mentioning
confidence: 99%